Navigation Links
Burrell Behavioral Health Improves Care and Patient Security by Implementing Hyland Software's OnBase
Date:3/1/2013

ions' needs for document and process management with OnBase, an enterprise content management (ECM) software suite. As OnBase has evolved through consistent product innovation, it remains focused on automating business processes that depend on documents, content and people to operate more effectively.

OnBase enables healthcare organizations to provide better patient care by providing instant access to clinical and financial content normally outside of core IT applications. Every day, more than 1,600 healthcare organizations use OnBase to complete patient records, eliminate reimbursement delays and enhance business processes. Tailored for departments and comprehensive for the enterprise, OnBase is designed to grow with an organization, whether it chooses an on-premise or software as a service (SaaS) model. For more information about Hyland Software's ECM solutions for healthcare, please visit Hyland.com/Healthcare.

Media contact:
Megan Klingshirn
(440) 788-4988
megan.klingshirn@hyland.com


'/>"/>
SOURCE Hyland Software
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lexicon To Present At The Cowen Healthcare Conference
2. Pamlab Announces Agreement for Sale of Business to Nestle Health Science
3. 2013 Iraq Health Care Sector Outlook
4. BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland
5. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
6. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
7. Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting
8. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
9. Life Technologies to Present at Barclays Global Healthcare Conference
10. Infinata's BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
11. Health Canada bewilligt gesundheitsbezogene Angaben für fünf probiotische Rezepturen von Lallemand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- Research and Markets ( ... "Biotechnology for the Non-Biotechnologist" conference to ... ideal for non-Scientists and Scientists needing to understand ... biotechnology. Ideal for Non-Scientists and Scientists ... and potential of biotechnology Why you ...
(Date:7/6/2015)... , July 6, 2015 ImmunoCellular Therapeutics, Ltd. ... an agreement with Novella Clinical (Novella), to ... patients with newly diagnosed glioblastoma. Novella is a full-service, ... to small to mid-sized oncology companies. The ICT-107 phase ... the US, Europe and ...
(Date:7/3/2015)... , July 3, 2015 ... voivat hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Open Innovation in Science" -jatkokoulutusohjelmaan ... Boltzmann Gesellschaftin (LBG) tekemän, kansainvälisiä ... mukaan terveystieteiden kaksi suurinta haastetta ...
(Date:7/3/2015)... July 3, 2015 ... september 2015 på  http://www.openinnovationinscience.at till det ... Science" som hålls i Wien ... undersökning med internationella forskare och vetenskapsmän som ... hälsovetenskapens två största utmaningar bristen på incitament ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3
... 2011 GeoVax Labs, Inc. (OTCQB/OTCBB: ... prevent and fight Human Immunodeficiency Virus (HIV) infections, ... notice of award for the Integrated Preclinical/Clinical AIDS ... program. This grant was originally awarded ...
... 16, 2011 PharmAthene, Inc. (NYSE Amex: ... biological and chemical threats, announced today that the Company ... Department of Defense (DoD) Broad Agency Announcement for studies ... for the bioproduction of its nerve agent medical countermeasure ...
... Calif., Aug. 15, 2011 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the second quarter of 2011. Total ... million, representing 45% growth over total revenues of $2.6 million ...
Cached Biology Technology:GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program 2GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program 3Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program 2Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program 3Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program 4diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 2diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 3diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 4diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 5
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/24/2015)... This report provides market analysis of the ... It contains an analysis of the drivers, challenges, and ... from the short, medium, and long term perspective landscapes. ... and technology trends that currently, prevail in the market. ... to efficiently manage the increasing marine traffic and increasing ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... -- Researchers at Children,s Hospital Boston report that an enzyme ... for regenerating damaged axons (nerve fibers) in a live animal ... findings, published online by Nature Neuroscience on October ... as a possible means of treating stroke, spinal cord damage ...
... Among the many changes in the ocean is the expansion ... dead zones, which affect the processes by which carbon is ... activities that impact the rate and magnitude of ocean carbon ... known about the metabolism of OMZ microbes and how they ...
... sex-based biological differences extend to genetic expression in cerebral ... later divergences in how our brains develop. This is ... Elena Jazin and Bjrn Reinius, which has been published ... Psychiatry . Professor Elena Jazin and doctoral student ...
Cached Biology News:Master regulator found for regenerating nerve fibers in live animals 2Model microbial community for studying expanding dead zones characterized 2Model microbial community for studying expanding dead zones characterized 3Sex-based prenatal brain differences found 2
... Serum • Cyno serum is collected off the clot ... years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
3'-O-Methylguanosine 5'-Triphosphate, Sodium, 1 umol. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
Recombinant Viral CCI/Fc Chimera, CF...
... 1 ml. Improves reproducibility and ... preventing streaking.Eliminates extra spots caused ... proteins throughout entire 2-D runs, ... patterns.Ideal for both analytical and ...
Biology Products: